Thomson Reuters Drug News

  • HOME
  • SYSTEM REQUIREMENTS
  • SUPPORT
  • ABOUT US

 

Thomson Reuters Drug News

Dynamic, relevant drug news and email alerts posted every business day

Every business day, Thomson Reuters Drug News selects the latest, most important drug discovery and development news, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance.


You can search quickly on all sources, limiting your search to the period of time, drug name, patent number, company, university, institute, therapeutic category or group, type of compound, or information source relevant to your research. You can then link through to Thomson Reuters Integrity ® to read the full report and explore its contextual information. Thomson Reuters Drug News contains an archive of news covering drug R&D since 1996, with chemical structure images.

editor's choice

GSK to acquire Cellzome

Wed May 16, 2012 | Section: Company News


Image Placeholder

GlaxoSmithKline (GSK) has entered into an agreement to acquire the shares that it does not currently own in Cellzome for GBP 61 million in cash. GSK, which currently owns a 19.98% equity interest in Cellzome, will assume full control of the company, with Cellzome becoming part of GSK's R&D organization. Simultaneous with the acquisition, Cellzome ...

 

Full Article arrow

 

DDN

 

Today's News Sample
bulletWed May 16, 2012 | Section: Cancer
FDA approves TG Therapeutics' IND for phase I/II ublituximab study
bulletWed May 16, 2012 | Section: Cancer
Recombinant vectors targeting NY-ESO-1 assessed in phase II trials
bulletWed May 16, 2012 | Section: Cardiovascular Disorders
Cardiac function improves in preclinical study of PLX cells

 

Marketing Ad

 

Starting Line

An alerting service presenting a table, updated weekly, of the most promising compounds entering preclinical development, lead compounds and new mechanisms of action.


Pipeline on the Move

A weekly alerting service from Integrity presenting changes detected in the status of drugs currently under active development.

Top of Page
Latest Conferences Sample
bulletMay 9 - May 12 2012, Raleigh
72nd Annual Meeting of the Society for Investigative Dermatology
bulletMay 6 - May 10 2012, Fort Lauderdale
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
bulletMay 5 - May 9 2012, Philadelphia
165th Annual Meeting of the American Psychiatric Association
bulletMay 4 - May 8 2012, Boston
99th Annual Meeting of the American Association of Immunologists (AAI)
bulletMay 1 - May 3 2012, Glasgow
Annual Meeting of the British Society for Rheumatology (BSR) and The British Health Professionals in Rheumatology Spring Meeting (BHPR)
bulletApr 21 - Apr 25 2012, San Diego
Experimental Biology 2012
bulletApr 21 - Apr 28 2012, New Orleans
64th Annual Meeting of the American Academy of Neurology (AAN)
bulletApr 18 - Apr 21 2012, Dubai
World Congress of Cardiology
bulletApr 18 - Apr 22 2012, Barcelona
47th Annual Meeting of the European Association for the Study of the Liver
bulletApr 18 - Apr 20 2012, Chicago
Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
Top of Page
Login

Please enter your username and
password to login

Error icon You must log in to see this content

 

Reset Password

Today's News

Conference Archive

© THOMSON REUTERS
  • Legal Information